About
Cristae Therapeutics develops small-molecule drugs designed to restore mitochondrial function for the treatment of neurodegenerative and rare diseases, supported by over a decade of research and a proprietary library of more than 700 novel compounds.
Explore Cristae Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.